Powers and Trobridge examine the impact of fetal bovine serum (FBS) on viral vector production. They demonstrate that there can be significant variability between different FBS production lots in the resultant viral titer of both foamy and lentivirus vectors.
Get full access to this article
View all access options for this article.
References
1.
BouardD., Alazard-DanyD., CossetF.L.2009. Viral vectors: From virology to transgene expression. Br. J. Pharmacol., 157:153–165.
2.
BrunnerD., FrankJ., ApplH.et al.2010. Serum-free cell culture: The serum-free media interactive online database. Altex, 27:53–62.
3.
CartierN., Hacein-Bey-AbinaS., BartholomaeC.C.et al.2009. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science, 326:818–823.
4.
ChuF.C., JohnsonJ.B., OrrH.C.et al.1973. Bacterial virus contamination of fetal bovine sera. In Vitro, 9:31–34.
5.
DenningW., DasS., GuoS.et al.2013. Optimization of the transductional efficiency of lentiviral vectors: Effect of sera and polycations. Mol. Biotechnol., 53:308–314.
6.
DiGiustoD.L., KrishnanA., LiL.et al.2010. RNA-based gene therapy for HIV with lentiviral vector-modified CD34+ cells in patients undergoing transplantation for AIDS-related lymphoma. Sci. Transl. Med., 2:36ra43.
7.
FalknerE., ApplH., EderC.et al.2006. Serum free cell culture: The free access online database. Toxicol In Vitro, 20:395–400.
8.
GasparH.B., CoorayS., GilmourK.C.et al.2011. Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency. Sci. Transl. Med., 3:97ra79.
9.
JensenT.W., ChenY., MillerW.M.2003. Small increases in pH enhance retroviral vector transduction efficiency of NIH-3T3 cells. Biotechnol. Prog., 19:216–223.
10.
KiemH.P., WuR.A., SunG.et al.2010. Foamy combinatorial anti-HIV vectors with MGMTP140K potently inhibit HIV-1 and SHIV replication and mediate selection in vivo. Gene Ther., 17:37–49.
11.
LinialM.L.1999. Foamy viruses are unconventional retroviruses. J. Virol., 73:1747–1755.
12.
MaetzigT., BaumC., SchambachA.2012. Retroviral protein transfer: Falling apart to make an impact. Curr. Gene Ther., 12:389–409.
13.
McTaggartS., Al-RubeaiM.2002. Retroviral vectors for human gene delivery. Biotechnol. Adv., 20:1–31.
14.
PriceP.J., GregoryE.A.1982. Relationship between in vitro growth promotion and biophysical and biochemical properties of the serum supplement. In Vitro, 18:576–574.
15.
RahmanH., QasimM., SchultzeF.C.et al.2011. Fetal calf serum heat inactivation and lipopolysaccharide contamination influence the human T lymphoblast proteome and phosphoproteome. Proteome Sci., 9:71.
16.
RodriguesA.F., CarmoM., AlvesP.M., CoroadinhaA.S.2009. Retroviral vector production under serum deprivation: The role of lipids. Biotechnol. Bioeng., 104:1171–1181.
17.
RomenF., BackesP., MaterniakM.et al.2007. Serological detection systems for identification of cows shedding bovine foamy virus via milk. Virology, 364:123–131.
18.
RossiC.R., KieselG.K.1974. Antibody to viruses affecting cattle in commercial tissue culture grade fetal calf serum. Appl. Microbiol., 27:114–117.
19.
TrobridgeG.D., WuR.A., HansenM.et al.2010. Cocal-pseudotyped lentiviral vectors resist inactivation by human serum and efficiently transduce primate hematopoietic repopulating cells. Mol. Ther., 18:725–733.
